Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalActive in the last 2 years

Dafei Xie

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. Fisetin disrupts mitochondrial homeostasis via superoxide dismutase 2 acetylation in pancreatic adenocarcinoma. First author DOI 10.1002/ptr.8296↗
  2. Scaffold-based three-dimensional cell model of pancreatic cancer is more suitable than scaffold-free three-dimensional cell model of pancreatic cancer for drug… Co-author DOI 10.1007/s10616-022-00553-z↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liping Cao · 2 shared papers, 2022–2024 · strength 0.44
  2. Shengnan Jia · 1 shared paper, 2024 · strength 0.24
  3. Yimin Ding · 1 shared paper, 2024 · strength 0.24
  4. Dongnan Ping · 1 shared paper, 2022 · strength 0.20
  5. Shengnan Jia · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.